Making Better Leaders Out of Alpha Males and Females

Credit: © JAMES PAULS" /> Credit: © JAMES PAULS Ellen McMahon was a rising star as leader of the cardiovascular research group at Pharmacia before its merger with Pfizer. But she started to get grumbling from her team, and talks about management style from her bosses. McMahon says her staff "was struggling with my leadership, they didn?t feel involved in making decisions. I was more in the mode of driving towards goals rather than considering team dynamics." McMahon, an acknowledg

Written byKen Wilan
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Ellen McMahon was a rising star as leader of the cardiovascular research group at Pharmacia before its merger with Pfizer. But she started to get grumbling from her team, and talks about management style from her bosses. McMahon says her staff "was struggling with my leadership, they didn?t feel involved in making decisions. I was more in the mode of driving towards goals rather than considering team dynamics." McMahon, an acknowledged "alpha female," decided she could be a better manager. "Every one of your strengths turns into a weakness when you over play it," she says.

McMahon, now a senior director in the field-based medical group at Pfizer, is one of the success stories for Eddie Erlandson, a former vascular surgeon who is now an executive coach. Erlandson?s new book, written with his business partner and wife Kate Ludeman, is named for what he says is a typical description for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies